Moderna

Sales drop 43% in third quarter as primary immunisation drives reach completion

Pharmaceutical companies hunt for new revenue streams as pandemic becomes endemic

Top jab makers lose combined $10bn of market value amid fears over growing public apathy

Vaccines also include original version of virus

US biotech claims rival Covid vaccine makers infringed patents underpinning jabs

New book details how talent, leaps of faith and dogged determination brought the pharma company to world attention in 2020

President hails ‘monumental step forward’ in battle against virus but parents have been more cautious in inoculating children

Interim results from its clinical trial showed the jab is safe and highly effective, company said

Interview: Horizon Therapeutics chief Tim Walbert sees Dublin at heart of its international expansion

With the virus rampant despite jabs, trials are underway to create intranasal vaccines

Pyongyang says it has kept its population Covid-free by sealing the country’s borders

Adoption of committee reports confirms extension intended to facilitate travel

Cantillon: Emerging markets surprise observers with vaccine preferences

Proxy advisers back shareholder resolutions as new shot shows promising results

Bosses of Pfizer, BioNTech and Moderna also see paper wealth grow as share prices surge

Ukraine’s president Zelenskiy makes cameo at scandal free ceremony after Oscars chaos

Request is significantly broader than Pfizer and its German partner BioNTech’s

‘We don’t need to push it in places we are not needed or wanted,’ says drugmaker’s VP

Three doses can protect against serious illness and death for a long time, studies suggest

European Medicines Agency says no evidence to suggest vaccines affect fertility